 | Up a level |
Cybulska, Barbara, Klosiewicz-Latoszek, Longina, Penson, Peter E 
ORCID: 0000-0001-6763-1489, Nabavi, Seyed Mohammad, Lavie, Carl J, Banach, Maciej and ILEP, Int Lipid Expert Panel
(2021)
How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors.
PROGRESS IN CARDIOVASCULAR DISEASES, 67.
65 - 74.
Ruscica, Massimiliano, Penson, Peter E ORCID: 0000-0001-6763-1489, Ferri, Nicola, Sirtori, Cesare R, Pirro, Matteo, Mancini, GB John, Sattar, Naveed, Toth, Peter P, Sahebkar, Amirhossein, Lavie, Carl J et al (show 4 more authors)
(2021)
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases-A position paper from the International Lipid Expert Panel (ILEP).
PROGRESS IN CARDIOVASCULAR DISEASES, 67.
40 - 52.
Banach, Maciej, Catapano, Alberico L, Cicero, Arrigo FG, Escobar, Carlos, Foger, Bernhard, Katsiki, Niki, Latkovskis, Gustavs, Rakowski, Michal, Reiner, Zeljko, Sahebkar, Amirhossein et al (show 3 more authors)
(2022)
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel.
PHARMACOLOGICAL RESEARCH, 183.
106370-.